NovoVia, Inc.

NovoVia aims to cure infertility due to ovarian or testicular failure using eggs or sperm derived from an individual's stem cells.

  • Stage Not Set
  • Industry Biotechnology
  • Location New York City, NY, USA
  • Currency USD
  • Founded June 2013
  • Employees 4

Company Summary

NovoVia brings together some of the leading researchers in the field of infertility - led by Renee Reijo Pera (Director of Human Pluripotent Stem Cell Research at Stanford) - capable of translating the latest, ground-breaking research in infertility (including their own) into clinical practice in 2-3 years. Its mission is to allow all people the possibility of genetic offspring - notably, those not helped by IVF and other current forms of ART.

Team

  • Renee Reijo Pera
    Professor

    Co-founder; PhD; George D Smith Professor of Stem Cell Biology & Regenerative Medicine, Stanford University; Director, Human Pluripotent Stem Cell Research & Education, Stanford University

  • Carlos Simon
    Professor

    Co-founder; MD, PhD; Professor of Obstetrics & Gynecology, University of Valencia (Spain); Scientific Director, IVI Foundation (Spain; one of the largest IVF centers in the world); Adjunct Clinical Professor, Stanford University School of Medicine (U.S.A.)

  • Kyle Orwig
    Professor

    Co-founder; PhD; Associate Professor of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh; Director, Fertility Preservation Program, Magee-Women's Research Institute (Pittsburgh)

  • Joseph Gottfried
    Dr.

    Co-founder, President & Secretary of NovoVia; MD, JD; Board-certified internist; Formerly, McKinsey & Company (New York), McKinsey Hospital Institute (London)

  • Joseph Gottfried

Advisors

  • Stephen B. Thau (Morrison & Foerster, Corporate Counsel); Terri Shieh-Newton (Morrison & Foerster, Patent Counsel)
    Lawyer
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free